Xevant
PrivateLast Round
Series A
Feb 8, 2024
Total Funding Raised
$17.22M
Company Overview
Xevant is a healthcare technology company that provides a real-time, AI-powered analytics platform for organizations managing pharmacy benefits.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Vertical SaaS, Business Intelligence, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xevant Comparables
Compare Xevant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scripta Insights | 79% | |
| Truveris | 76% | |
| McKesson | 71% |
Xevant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 8, 2024 | ||||
| Growth Equity | Mar 14, 2023 | ||||
| Series A | Dec 29, 2021 | ||||
| VC Round | Jan 6, 2021 |
Key People
Founding team and executive leadership
Xevant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Decathlon Capital Partners | Series A |
| Tech Council Ventures | Series A, VC Round |
| Boston Millennia Partners | VC Round |
| Martinson Ventures | Series A, VC Round |
| Boston Millennia Partners | Series A, VC Round |
| HCAP Partners | Series A, Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Named a 2025 Modern Healthcare Best in Business company.
- Jun 11, 2025
Launched VerX, a new platform for pharmacy benefit optimization.
Xevant Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Xevant's valuation, stock price, and market status.
Is Xevant a public or private company?
Xevant is a private company.
What is the current stock price of Xevant?
Xevant is a private company with no public stock price. No recent secondary market data is available.
How much is Xevant worth (valuation)?
Valuation information for Xevant is not publicly available.
Can I buy Xevant stock?
Xevant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Xevant's last funding round?
Xevant's most recent funding round was Series A Extension on February 8, 2024.
Who are the main investors in Xevant?
Key investors in Xevant include Decathlon Capital Partners, Tech Council Ventures, Boston Millennia Partners, Martinson Ventures, HCAP Partners.
Will Xevant IPO soon?
No public IPO plans have been announced for Xevant.
How can I track Xevant secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xevant's secondary market activity and sign up for updates.